In-silico identification and validation of Silibinin as a dual inhibitor for ENO1 and GLUT4 to curtail EMT signaling and TNBC progression. - Dheepika Venkatesh; Shilpi Sarkar; Thirukumaran Kandasamy; Siddhartha Sankar Ghosh (Comput. Biol. Chem., 2025)